The share price of Esperion Therapeutics ESPR lost 54.3% on Mar 16 after management reported a disagreement with one of its partners over certain milestone payments. Last year,Esperion announced that ...

Esperion Therapeutics is back in focus after its fair value estimate was revised from about US$6.50 to roughly US$3.19 per ...

The average one-year price target for Esperion Therapeutics (NASDAQ:ESPR) has been revised to 11.35 / share. This is an increase of 8.24% from the prior estimate of 10.48 dated August 31, 2023. The ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.